INDVIndivior Pharmaceuticals, Inc.

$35.84+59% 1Y

$35.84

$22.7352 weeks$41.47

Is it growing?

Excellent

Growing: revenue growing +13% year on year, earnings up +232% year on year, and operating margin widening (+12.7 points).

3 good

Revenue trend+13% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend+232% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+12.7 points operating

Trailing-twelve-month operating margin, 31.5% now against 18.9% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is INDV growing?

Indivior Pharmaceuticals, Inc. has grown revenue 11% a year over three years and 11% a year over five.

+11%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +11%
Revenue growth, 5-year rate · +11% over three · growth has slowed since the five-year average
Years of annual history on file: 4
Years of annual history on file · FY2022 to FY2025, as filed

Details›